One hundred fecal specimens obtained from patients with acute gastroenteritis were tested for rotavirus with nine commercial immunoassays to evaluate the sensitivity, specificity, predictive value, and diagnostic accuracy of these assays. Kits evaluated included two monoclonal antibody-based enzyme immunoassays (EIAs) ( Rotavirus is a major cause of gastroenteritis in children throughout the world (4, 15). In addition, rotavirus is a common nosocomial infection on wards for young children (7, 31, 33) and is a problem in the day-care setting (16). Recently outbreaks of rotavirus infection have also been identified in elderly patients (13, 20 Reference assay. All specimens were tested by the reference method, a direct double-antibody sandwich microplate EIA described by Grauballe et al. (12). This assay was selected as the reference method because it is more sensitive than electron microscopy (12) and is comparable to the indirect enzyme immunoassay used as the World Health Organization reference standard (12). The reference assay was performed as follows. Alternate wells of a polyvinyl 96-well plate were coated with a 1:50 dilution of hyperimmune rabbit anti-human rotavirus antibody (DAKO Corp., Santa Barbara, Calif.) and normal rabbit immunoglobulin. The plate was incubated for 1 h at room temperature. The wells were emptied and washed five times with phosphatebuffered saline containing 0.5% Tween 20 with a hand-held wash apparatus (Miniwasher-12; Skatron, Inc., Sterling, Va.) The fecal specimens, prepared as 10% suspensions in phosphate-buffered saline-0.5% Tween 20 containing 0.5% bovine serum albumin, were added to duplicate wells coated with anti-rotavirus and control sera. After incubation for 1 h at room temperature the specimen was aspirated, and the plates were washed as described above. A 0.04% solution of normal rabbit serum was added to each well to block nonspecific reactions, and the plates were incubated for 1 h at room temperature.
Rotavirus is a major cause of gastroenteritis in children throughout the world (4, 15) . In addition, rotavirus is a common nosocomial infection on wards for young children (7, 31, 33) and is a problem in the day-care setting (16) . Recently outbreaks of rotavirus infection have also been identified in elderly patients (13, 20) . The accurate diagnosis of rotavirus infections is important not only for the rapid diagnosis of infection in patients with gastroenteritis but also for the identification of infected individuals who are potential sources of infection to others.
Human rotaviruses are difficult to cultivate in commonly used cell culture systems (37, 39) ; therefore other methods of rotavirus identification have been developed. Originally, electron microscopy was used (9) , but recently many different techniques, including radioimmunoassay (22) , enzyme immunoassay (EIA) (40) , immune adherence hemagglutination (21) , reversed passive hemagglutination (35) , staphylococcal coagglutination (38) , latex agglutination (36) , agglutination of antibody-coated erythrocytes (2) , counterimmunoelectrophoresis (23) , complement fixation (24) , immunofluorescence in cell culture (1) , fluorescent virus precipitation (29) , and polyacrylamide gels to detect rotaviral nucleic acid (14) , have been employed for the detection of rotaviruses in stool samples.
Immunoassays have become the standard method for the detection of rotavirus in stool specimens. Commercial immunoassay kits for detecting rotavirus are now available and include monoclonal antibody-based EIAs, polyclonal antibody-based EIAs, and latex agglutination assays (30 Reference assay. All specimens were tested by the reference method, a direct double-antibody sandwich microplate EIA described by Grauballe et al. (12) . This assay was selected as the reference method because it is more sensitive than electron microscopy (12) and is comparable to the indirect enzyme immunoassay used as the World Health Organization reference standard (12 Laemmli (19) with silver staining of rotaviral RNA as follows. Stool specimens were suspended in EDTA and then sequentially extracted with 1,1,2-trichloro-1,2,2-trifluoroethane and phenol-chloroform to obtain rotaviral RNA. The RNA was ethanol precipitated and dissolved in Laemmli buffer. Each sample was applied to a discontinuous 7.5% polyacrylamide-7 M urea gel with a 3% stacking gel and run at 95 V for 17 h. Gels were stained by using a silver stain kit (Bio-Rad Laboratories, Richmond, Calif.).
Blocking assay. Specimens positive by one or both of the monoclonal antibody-based EIAs but negative by the reference EIA and PAGE were further evaluated by a blocking assay. The specimens were incubated with 1:5 dilutions of bovine anti-rotavirus antiserum (NIAID V-710-501-553; American Type Culture Collection, Rockville, Md.) or normal bovine serum negative for rotavirus antibody for 1 h at 37°C before the performance of the EIA as directed by the manufacturer. A stool sample having a reduction in absorbance of at least 50% in the anti-rotavirus serum-treated specimen as compared with the normal serum-treated specimen was considered positive for rotavirus antigen.
Data analysis. Results of the commercial assays were compared with results obtained with the reference assay and the blocking assay. True-positives are defined as specimens positive by both the reference or blocking assay and the commercial assay, whereas false-positives are positive by the commercial assay but not by the reference or blocking assays. False-negatives are specimens with positive results on the reference or blocking assay but negative results on the commercial assay. Sensitivity or the true-positive rate was determined by dividing the number of specimens positive in both the commercial and reference or blocking assay by the total number positive in the reference or blocking assay. Specificity or the true-negative rate was determined by dividing the number of specimens negative in both the commercial and reference or blocking assay by the total number negative in the reference or blocking assays. The positive predictive value, the percentage of truly infected individuals among those with positive tests, was determined by dividing the number of specimens positive in both the commercial and reference or blocking assay by the total number positive in the commercial assay. The negative predictive value, the percentage of truly uninfected individuals among those with negative tests, was determined by dividing the number of specimens negative in both the commercial and reference or blocking assay by the total number negative in the commercial assay. Diagnostic accuracy was determined by dividing the number of specimens with positive results in both tests plus the number of specimens with negative results in both tests by the total number of specimens tested. All ofthe above measures were multiplied by 100 and are expressed as percentages.
RESULTS
The reference EIA found 38 of the 100 stool samples from patients with gastroenteritis to be positive for rotavirus, whereas 62 were negative. PAGE was done on 41 specimens in which the results of the reference assay and at least one commercial immunoassay were discordant. The results of PAGE were in complete agreement with the reference EIA; the 6 specimens positive by the reference assay all contained rotaviral RNA, whereas none of the 35 negative specimens had detectable RNA. Three additional specimens which were positive by a monoclonal antibody-based EIA but negative by thé reference EIA and PAGE were further tested by a blocking assay. In two of the three specimens the blocking assay found rotavirus antigen which was not detected by the reference assay or PAGE. One of the two specimens positive by blocking assay had low absorbance readings in both monoclonal antibody-based EIAs, whereas the other specimen had been read as negative in the reference EIA because of greater absorbance in the control well than that in' the test well.
The results of the two monoclonal antibody-based EIAs are compared with the reference and blocking assays in Table 1 . The number of true-positives varied from a high of 37 in the Virogen assay to a low of 28 in the Wellcome latex test. Virogen gave the largest number of false-positives (12), whereas Wellcome had the largest number of falsenegatives (8) . Nonspecific reactions were seen uncommonly. Overall, Rotastat had the highest diagnostic accuracy (96%) of the latex agglutination assays.
DISCUSSION
The choice of a reference standard for the evaluation of rotavirus assays is important in determining the clinical utility of assays and in comparisons of evaluations of assays done in a variety of laboratory settings. The reference method must be able to accurately predict the presence of rotavirus in clinical specimens. Reference standards used in prior evaluations of rotavirus assays have included electron microscopy (5, 17, 26, 28, 32, 34) , a reference EIA (6, 8, 11, 25, 41) , or PAGE of rotaviral RNA (27) . The reference microplate EIA used in this evaluation was selected on the basis of its superiority over electron microscopy (12) and its comparability with PAGE; however it has been combined with a blocking assay because that assay identified as positive two specimens positive by monoclonal antibodybased EIAs and negative by reference EIA-PAGE. These specimens are interpreted as true positives with very small amounts of viral antigen not detectable by the reference techniques. Monoclonal antibody-based EIAs have been found to be capable of detecting rotavirus in specimens containing 10-fold fewer virions than those positive by electron microscopy or an indirect enzyme-linked immunosorbent assay similar to the reference EIA (10).
The results of this study indicate that the EIA kits are, in general, more sensitive and more specific and have greater diagnostic accuracy than latex agglutination tests. There is an exception however: one polyclonal antibody-based EIA, Rotazyme II, had lower specificity and diagnostic accuracy than the latex agglutination assays evaluated. Lack of sensitivity has been a problem in many evaluations of latex agglutination assays (3, 30) and has been particularly apparent when testing stool from patients late in the course of illness when smaller amounts of antigen may be present (25, 28 (18) and may be due to rheumatoid factor-like substances in stool (42) . The specificity problem was seen in all age groups tested, including adults, not exclusively in neonatal specimens, as has been reported by Krause et al. (18) . The inclusion of a preimmune serum control, as is done in the reference assay and the IDL assay, allows the differentiation of nonspecific reactions from true positives in these tests, but this control is not included in Rotazyme Il.
Other factors related to test performance, such as speed, expense, and simplicity, also need to be evaluated. Table 2 summarizes performance time, cost per test, and equipment needs for the nine tests evaluated in this study. Latex agglutination tests are more rapid than EIAs and do not require expensive equipment. Hence the latex agglutination tests with the highest sensitivity and specificity are suitable for use in the emergency room, physician's office, or small hospital laboratory where speed and simplicity are needed. The monoclonal antibody-based EIAs are the most costly but have the advantage of rapid performance times and highest sensitivity. Polyclonal antibody-based tests are the least expensive but most time consuming.
The choice of the rotavirus assay will depend to a great extent on the requirements of the individual laboratory. Reference laboratories may wish to select tests with the highest sensitivity and specificity, such as the monoclonal antibody-based EIAs or, if cost is an issue, a polyclonal antibody-based EIA with high sensitivity and specificity. Latex agglutination assays are best utilized in situations where a small number of specimens are to be tested, since latex assays cannot be automated, and where simplicity and speed are of importance. 
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